Literature DB >> 12933880

Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival.

Mingqun Lin1, Yasuko Rikihisa.   

Abstract

Ehrlichia chaffeensis and Anaplasma phagocytophilum are agents of human monocytic and granulocytic ehrlichioses, respectively. They are extremely sensitive to mechanical stress and are pleomorphic gram-negative bacteria. Membrane incorporation of cholesterol from the eukaryotic host is known to be essential for other fragile and pleomorphic bacteria and mycoplasmas that lack a cell wall. Thus, we tested whether cholesterol is required for E. chaffeensis and A. phagocytophilum. Using a freeze fracture technique and biochemical analysis, these bacteria were found to contain significant levels of membrane cholesterol. These bacteria lack genes for cholesterol biosynthesis or modification. However, host cell-free bacteria had the ability to take up directly exogenous cholesterol or NBD-cholesterol, a fluorescent cholesterol derivative. Treatment of the bacteria with cholesterol extraction reagent methyl-beta-cyclodextrin caused their ultrastructural changes. Furthermore, pretreatment of the bacteria with methyl-beta-cyclodextrin or NBD-cholesterol deprived these bacteria of the ability to infect leukocytes, thus killing these obligate intracellular bacteria. Analysis of E. chaffeensis and A. phagocytophilum genome sequences revealed that these bacteria lack all genes for the biosynthesis of lipid A and most genes for the biosynthesis of peptidoglycan, which confer structural strength to gram-negative bacteria. Taken together, these results suggest that human ehrlichiosis agents became cholesterol dependent due to the loss of these genes. As the first report of gram-negative bacteria incorporating cholesterol for survival, these findings offer insight into the unique nature of their parasitism and imply that cholesterol is important in the control of human ehrlichioses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933880      PMCID: PMC187327          DOI: 10.1128/IAI.71.9.5324-5331.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Ehrlichial strategy for survival and proliferation in leukocytes.

Authors:  Y Rikihisa
Journal:  Subcell Biochem       Date:  2000

Review 2.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

3.  Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1.

Authors:  M J Herron; C M Nelson; J Larson; K R Snapp; G S Kansas; J L Goodman
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

4.  LYSIS OF PLEUROPNEUMONIA-LIKE ORGANISMS BY STAPHYLOCOCCAL AND STREPTOCOCCAL TOXINS.

Authors:  A W BERNHEIMER; M DAVIDSON
Journal:  Science       Date:  1965-05-28       Impact factor: 47.728

5.  Mechanisms of evolution in Rickettsia conorii and R. prowazekii.

Authors:  H Ogata; S Audic; P Renesto-Audiffren; P E Fournier; V Barbe; D Samson; V Roux; P Cossart; J Weissenbach; J M Claverie; D Raoult
Journal:  Science       Date:  2001-09-14       Impact factor: 47.728

6.  Rapid activation of protein tyrosine kinase and phospholipase C-gamma2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells.

Authors:  Mingqun Lin; Michael X Zhu; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 7.  Tlr4: central component of the sole mammalian LPS sensor.

Authors:  B Beutler
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

8.  Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox.

Authors:  R Banerjee; J Anguita; D Roos; E Fikrig
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 9.  Clinical and biological aspects of infection caused by Ehrlichia chaffeensis.

Authors:  Y Rikihisa
Journal:  Microbes Infect       Date:  1999-04       Impact factor: 2.700

Review 10.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more
  129 in total

1.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

3.  Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia.

Authors:  Alvaro Toledo; Javier D Monzón; James L Coleman; Juan C Garcia-Monco; Jorge L Benach
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

4.  M1 and M2 Macrophages Polarization via mTORC1 Influences Innate Immunity and Outcome of Ehrlichia Infection.

Authors:  Ibrahim Ahmed; Nahed Ismail
Journal:  J Cell Immunol       Date:  2020

Review 5.  Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

Authors:  David H Walker; Nahed Ismail; Juan P Olano; Jere W McBride; Xue-Jie Yu; Hui-Min Feng
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

6.  Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins.

Authors:  Kelly A Brayton; Lowell S Kappmeyer; David R Herndon; Michael J Dark; David L Tibbals; Guy H Palmer; Travis C McGuire; Donald P Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

7.  Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway.

Authors:  Mohd Akhlakur Rahman; Zhihui Cheng; Junji Matsuo; Yasuko Rikihisa
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

8.  Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics.

Authors:  Yan Ge; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

Review 9.  Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins.

Authors:  Yasuko Rikihisa; Mingqun Lin
Journal:  Curr Opin Microbiol       Date:  2010-01-05       Impact factor: 7.934

Review 10.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.